跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ventar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ventar
Approved
STANDARD
Ventar
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4b306422fd809c68
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
4b306422fd809c68
Drug Approval Philippines Name
Ventar
Product Name
Ventar
Registration Number
DR-XY17858
Brand Name
Ventar
Generic Name
Salbutamol (as sulfate)
Dosage Form
Tablet
Dosage Strength
2 mg
Manufacturer
Hizon Laboratories, Inc.
Issuance Date
25 November 2021
Expiry Date
03 March 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4b306422fd809c68
Type
Standard
Back to Philippines FDA Approvals